<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ISBI 2013</title>
	<atom:link href="http://www.biomedicalimaging.org/2013/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.biomedicalimaging.org/2013</link>
	<description>International Symposium on BIOMEDICAL IMAGING: From Nano to Macro</description>
	<lastBuildDate>Mon, 08 Apr 2013 17:46:52 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=419</generator>
		<item>
		<title>HARDI Reconstruction Challenge</title>
		<link>http://www.biomedicalimaging.org/2013/hardi-reconstruction-challenge/</link>
		<comments>http://www.biomedicalimaging.org/2013/hardi-reconstruction-challenge/#comments</comments>
		<pubDate>Thu, 29 Nov 2012 07:07:07 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[2013 ISBI Grand Challenges]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=584</guid>
		<description><![CDATA[<p>	<strong>Alessandro Daducci</strong><br />
	 Signal Processing Lab (LTS5), EPFL, Switzerland</p>
<p>	<strong>Emmanuel Caruyer</strong><br />
	Department of Radiology, University of Pennsylvania, USA</p>
<p>	<strong>Maxime Descoteaux</strong><br />
	Sherbrooke Connectivity Imaging Lab (SCIL), Universit´e de Sherbrooke, Canada</p>
<p>	<strong>Jean-Philippe Thiran</strong><br />
	Signal Processing Lab (LTS5), EPFL, Switzerland<br />
	University Hospital Center (CHUV) and University of Lausanne (UNIL), Switzerland</p>
<p>	<b class="subhead">Website</b><br /><a target="_blank" href="http://hardi.epfl.ch/static/events/2013_ISBI/">http://hardi.epfl.ch/static/events/2013_ISBI/</a></p>
<p>	<b class="subhead">Challenge Abstract</b><br />
Validation is the bottleneck for the diffusion magnetic resonance imaging (MRI) community. Diffusion MRI is a powerful MRI modality which is sensitive to the random movement of the water molecules in biological tissues. By studying the anisotropy of this diffusion process in white matter it is possible to highlight structures otherwise invisible with other imaging modalities and to infer the neuronal wiring of the brain. The study of this connectivity is of major importance in a clinical perspective, with particular emphasis on neurological disorders which, nowadays, affect up to one billion people worldwide.</p>
<p>The state-of-the-art Diffusion Spectrum Imaging (DSI) [1] modality is known to provide good imaging quality but is too time-consuming to be of real interest for practical applications. Accelerated acquisitions, relying on a smaller number of sampling points, are thus required. In the last few years a multitude of new reconstruction approaches have been proposed to recover the local intra-voxel fiber structure. Some of them aim at improving the quality of the reconstructions while others focus on reducing the acquisition time. However, when a new algorithm is proposed, the performances are normally assessed with ad-hoc synthetic data and evaluation criteria. Hence, when proposing a new algorithm, it can be really difficult to compare the performances against the state-of-theart techniques. This aspect is even more crucial in a clinical perspective, as the availability of a comprehensive comparison of available reconstruction methods, highlighting strengths and weaknesses of each approach, might help clinicians in the choice of the most adequate diffusion MRI technique for a specific clinical application.</p>
<p>The diffusion MRI reconstruction challenge is organized with the aim to provide all researchers in this field with a common framework to assess the performances of their own algorithms and fairly compare their results against other approaches. The purpose of the contest is to compare different reconstruction schemes on the same synthetic data and under controlled conditions. The competitors will be asked to provide the best estimation of the configuration of fiber compartments of a common dataset by using their proposed algorithms.</p>]]></description>
				<content:encoded><![CDATA[<p>	<strong>Alessandro Daducci</strong><br />
	 Signal Processing Lab (LTS5), EPFL, Switzerland</p>
<p>	<strong>Emmanuel Caruyer</strong><br />
	Department of Radiology, University of Pennsylvania, USA</p>
<p>	<strong>Maxime Descoteaux</strong><br />
	Sherbrooke Connectivity Imaging Lab (SCIL), Universit´e de Sherbrooke, Canada</p>
<p>	<strong>Jean-Philippe Thiran</strong><br />
	Signal Processing Lab (LTS5), EPFL, Switzerland<br />
	University Hospital Center (CHUV) and University of Lausanne (UNIL), Switzerland</p>
<p>	<b class="subhead">Website</b><br /><a target="_blank" href="http://hardi.epfl.ch/static/events/2013_ISBI/">http://hardi.epfl.ch/static/events/2013_ISBI/</a></p>
<p>	<b class="subhead">Challenge Abstract</b><br />
Validation is the bottleneck for the diffusion magnetic resonance imaging (MRI) community. Diffusion MRI is a powerful MRI modality which is sensitive to the random movement of the water molecules in biological tissues. By studying the anisotropy of this diffusion process in white matter it is possible to highlight structures otherwise invisible with other imaging modalities and to infer the neuronal wiring of the brain. The study of this connectivity is of major importance in a clinical perspective, with particular emphasis on neurological disorders which, nowadays, affect up to one billion people worldwide.</p>
<p>The state-of-the-art Diffusion Spectrum Imaging (DSI) [1] modality is known to provide good imaging quality but is too time-consuming to be of real interest for practical applications. Accelerated acquisitions, relying on a smaller number of sampling points, are thus required. In the last few years a multitude of new reconstruction approaches have been proposed to recover the local intra-voxel fiber structure. Some of them aim at improving the quality of the reconstructions while others focus on reducing the acquisition time. However, when a new algorithm is proposed, the performances are normally assessed with ad-hoc synthetic data and evaluation criteria. Hence, when proposing a new algorithm, it can be really difficult to compare the performances against the state-of-theart techniques. This aspect is even more crucial in a clinical perspective, as the availability of a comprehensive comparison of available reconstruction methods, highlighting strengths and weaknesses of each approach, might help clinicians in the choice of the most adequate diffusion MRI technique for a specific clinical application.</p>
<p>The diffusion MRI reconstruction challenge is organized with the aim to provide all researchers in this field with a common framework to assess the performances of their own algorithms and fairly compare their results against other approaches. The purpose of the contest is to compare different reconstruction schemes on the same synthetic data and under controlled conditions. The competitors will be asked to provide the best estimation of the configuration of fiber compartments of a common dataset by using their proposed algorithms.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/hardi-reconstruction-challenge/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>3D Deconvolution Microscopy Challenge</title>
		<link>http://www.biomedicalimaging.org/2013/3d-deconvolution-microscopy-challenge/</link>
		<comments>http://www.biomedicalimaging.org/2013/3d-deconvolution-microscopy-challenge/#comments</comments>
		<pubDate>Mon, 29 Oct 2012 07:10:31 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[2013 ISBI Grand Challenges]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=591</guid>
		<description><![CDATA[<p>	<strong>Cedric Vonesch,</strong><br />
	Postdoctoral researcher, Biomedical Imaging Group,<br />
	Ecole Polytechnique Federale de Lausanne (EPFL) (Lausanne, Switzerland)</p>
<p>	<strong>Stamatis Lefkimmiatis,</strong><br />
	Postdoctoral researcher, Biomedical Imaging Group,<br />
	Ecole Polytechnique Federale de Lausanne (EPFL) (Lausanne, Switzerland)</p>
<p>	<strong>Laure Blanc-Feraud,</strong><br />
	CNRS Research Director, Laboratoir I3S (Sophia-Antipolis, France)</p>
<p>	<strong>Michael Unser,</strong><br />
	Head of the Biomedical Imaging Group,<br />
	Ecole Polytechnique Federale de Lausanne (EPFL) (Lausanne, Switzerland)</p>
<p>	<strong>Rainer Heintzmann,</strong><br />
	Head of the Microscopy Reseach Unit, Institute of Photonic Technology (Jena,<br />
	Germany) and Nanobiophotonics Professor for Physical Chemistry,<br />
	Friedrich-Schiller-Universitat (Jena, Germany)</p>
<p>	<strong>Arne Seitz,</strong><br />
	Head of the Bioimaging and Optics Platform,<br />
	Ecole Polytechnique Federale de Lausanne (EPFL) (Lausanne, Switzerland)</p>
<p>	<b class="subhead">Website</b><br />
<a target="_blank" href="http://bigwww.epfl.ch/deconvolution/challenge/">http://bigwww.epfl.ch/deconvolution/challenge/</a></p>
<p><b class="subhead">Challenge Abstract</b><br />
This document describes a project for a challenge in the framework of the 2013 ISBI conference. It is centered around 3D deconvolution in uorescence microscopy, which is one of the most common inverseproblem incarnations in bioimaging. Deconvolution also admits many variants with a one gradation in terms of complexity (e.g., blind deconvolution, space-variant image restoration or extension to super-resolution techniques such as structured illumination). We thus believe that the present project is suitable for creating a series of recurring annual challenges on the same topic.</p>
<p>The challenge will be organized as a three-stage tournament (training, qualification and final). Beyond selecting the most promising deconvolution algorithms and practitioners, our goal is to promote crossfertilization between the relatively independent communities of academic, open-source and commercial developers.</p>
<p>The evaluation of the results will be based on three tools: 1) a realistic 3D phantom of a mitotic cell that will serve as ground-truth data, 2) a physically motivated forward model and 3) a set of performance metrics chosen from three complementary categories (general-purpose, sample-specific and task-oriented metrics).</p>]]></description>
				<content:encoded><![CDATA[<p>	<strong>Cedric Vonesch,</strong><br />
	Postdoctoral researcher, Biomedical Imaging Group,<br />
	Ecole Polytechnique Federale de Lausanne (EPFL) (Lausanne, Switzerland)</p>
<p>	<strong>Stamatis Lefkimmiatis,</strong><br />
	Postdoctoral researcher, Biomedical Imaging Group,<br />
	Ecole Polytechnique Federale de Lausanne (EPFL) (Lausanne, Switzerland)</p>
<p>	<strong>Laure Blanc-Feraud,</strong><br />
	CNRS Research Director, Laboratoir I3S (Sophia-Antipolis, France)</p>
<p>	<strong>Michael Unser,</strong><br />
	Head of the Biomedical Imaging Group,<br />
	Ecole Polytechnique Federale de Lausanne (EPFL) (Lausanne, Switzerland)</p>
<p>	<strong>Rainer Heintzmann,</strong><br />
	Head of the Microscopy Reseach Unit, Institute of Photonic Technology (Jena,<br />
	Germany) and Nanobiophotonics Professor for Physical Chemistry,<br />
	Friedrich-Schiller-Universitat (Jena, Germany)</p>
<p>	<strong>Arne Seitz,</strong><br />
	Head of the Bioimaging and Optics Platform,<br />
	Ecole Polytechnique Federale de Lausanne (EPFL) (Lausanne, Switzerland)</p>
<p>	<b class="subhead">Website</b><br />
<a  target="_blank" href="http://bigwww.epfl.ch/deconvolution/challenge/">http://bigwww.epfl.ch/deconvolution/challenge/</a></p>
<p><b class="subhead">Challenge Abstract</b><br />
This document describes a project for a challenge in the framework of the 2013 ISBI conference. It is centered around 3D deconvolution in uorescence microscopy, which is one of the most common inverseproblem incarnations in bioimaging. Deconvolution also admits many variants with a one gradation in terms of complexity (e.g., blind deconvolution, space-variant image restoration or extension to super-resolution techniques such as structured illumination). We thus believe that the present project is suitable for creating a series of recurring annual challenges on the same topic.</p>
<p>The challenge will be organized as a three-stage tournament (training, qualification and final). Beyond selecting the most promising deconvolution algorithms and practitioners, our goal is to promote crossfertilization between the relatively independent communities of academic, open-source and commercial developers.</p>
<p>The evaluation of the results will be based on three tools: 1) a realistic 3D phantom of a mitotic cell that will serve as ground-truth data, 2) a physically motivated forward model and 3) a set of performance metrics chosen from three complementary categories (general-purpose, sample-specific and task-oriented metrics).</p>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/3d-deconvolution-microscopy-challenge/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STEPHEN WONG</title>
		<link>http://www.biomedicalimaging.org/2013/stephen-wong/</link>
		<comments>http://www.biomedicalimaging.org/2013/stephen-wong/#comments</comments>
		<pubDate>Fri, 08 Jun 2012 22:40:06 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[homespeakers]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=213</guid>
		<description><![CDATA[<p>Methodist Hospital Research Institute</p>]]></description>
				<content:encoded><![CDATA[<p>Methodist Hospital Research Institute</p>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/stephen-wong/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>JOHN SEDAT</title>
		<link>http://www.biomedicalimaging.org/2013/john-sedat/</link>
		<comments>http://www.biomedicalimaging.org/2013/john-sedat/#comments</comments>
		<pubDate>Fri, 08 Jun 2012 22:39:00 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[homespeakers]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=211</guid>
		<description><![CDATA[<p>University of California, San Francisco</p>
<p><span id="more-211"></span></p>
<p><img class=" wp-image-230  alignleft" style="margin-top: 0px; margin-bottom: 10px; margin-left: 0px; margin-right: 15px;" title="john_sedat" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/john_sedat-150x150.jpg" alt="John Sedat, PhD" width="160" height="160" /></p>
<p>John Sedat is Professor Emeritus in Biochemistry and Biophysics at the University of California, San Francisco. He received his Ph.D. in Biology from Caltech in Pasadena, CA in 1970 followed by postdoctoral study under Fred Sanger at the MRC in Cambridge, England. Subsequently, he spent approximately a year at the Hebrew University at Hadassah in Jerusalem, Israel where the Drosophila and chromosome study started.  Several years at Yale followed, and he has been at UCSF since 1977.</p>
<p>His scientific efforts are directed toward deciphering higher order chromosome structure, an unsolved problem, using Drosophila as a model system. Interestingly, those studies have required development, in collaboration with his colleague, David Agard, of several optical microscope systems to adequately visualize and quantitate the intricate chromosomal organization.</p>]]></description>
				<content:encoded><![CDATA[<p>University of California, San Francisco</p>
<p><span id="more-211"></span></p>
<p><img class=" wp-image-230  alignleft" style="margin-top: 0px; margin-bottom: 10px; margin-left: 0px; margin-right: 15px;" title="john_sedat" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/john_sedat-150x150.jpg" alt="John Sedat, PhD" width="160" height="160" /></p>
<p>John Sedat is Professor Emeritus in Biochemistry and Biophysics at the University of California, San Francisco. He received his Ph.D. in Biology from Caltech in Pasadena, CA in 1970 followed by postdoctoral study under Fred Sanger at the MRC in Cambridge, England. Subsequently, he spent approximately a year at the Hebrew University at Hadassah in Jerusalem, Israel where the Drosophila and chromosome study started.  Several years at Yale followed, and he has been at UCSF since 1977.</p>
<p>His scientific efforts are directed toward deciphering higher order chromosome structure, an unsolved problem, using Drosophila as a model system. Interestingly, those studies have required development, in collaboration with his colleague, David Agard, of several optical microscope systems to adequately visualize and quantitate the intricate chromosomal organization.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/john-sedat/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DAVID DONOHO</title>
		<link>http://www.biomedicalimaging.org/2013/devid-donoho/</link>
		<comments>http://www.biomedicalimaging.org/2013/devid-donoho/#comments</comments>
		<pubDate>Fri, 08 Jun 2012 22:36:11 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[homespeakers]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=212</guid>
		<description><![CDATA[<p>Stanford University</p>
<p><span id="more-212"></span></p>
<p>Donoho is a mathematician who has made fundamental contributions to theoretical and computational statistics, as well as to signal processing and harmonic analysis. His algorithms have contributed significantly to our understanding of the maximum entropy principle, of the structure of robust procedures, and of sparse data description.</p>
<p><strong>Research Interests</strong><br />
My theoretical research interests have focused on the mathematics of statistical inference and on theoretical questions arising in applying harmonic analysis to various applied problems. My applied research interests have ranged from data visualization to various problems in scientific signal processing, image processing, and inverse problems.</p>
<p><strong>Personal Website</strong><br />
<a href="http://stat.stanford.edu/~donoho/">stat.stanford.edu/~donoho/</a></p>]]></description>
				<content:encoded><![CDATA[<p>Stanford University</p>
<p><span id="more-212"></span></p>
<p>Donoho is a mathematician who has made fundamental contributions to theoretical and computational statistics, as well as to signal processing and harmonic analysis. His algorithms have contributed significantly to our understanding of the maximum entropy principle, of the structure of robust procedures, and of sparse data description.</p>
<p><strong>Research Interests</strong><br />
My theoretical research interests have focused on the mathematics of statistical inference and on theoretical questions arising in applying harmonic analysis to various applied problems. My applied research interests have ranged from data visualization to various problems in scientific signal processing, image processing, and inverse problems.</p>
<p><strong>Personal Website</strong><br />
<a href="http://stat.stanford.edu/~donoho/">stat.stanford.edu/~donoho/</a></p>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/devid-donoho/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>JOE GRAY</title>
		<link>http://www.biomedicalimaging.org/2013/joe-gray/</link>
		<comments>http://www.biomedicalimaging.org/2013/joe-gray/#comments</comments>
		<pubDate>Fri, 08 Jun 2012 21:30:59 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[homespeakers]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=207</guid>
		<description><![CDATA[<p>Oregon Health Sciences Institute</p>
<p><span id="more-207"></span></p>
<p><img class="size-full wp-image-243 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="Gray-Joe" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/111028-Gray-Joe120_2.jpg" alt="Gray-Joe" width="120" height="135" />Gray, a renowned genomics expert at Lawrence Berkeley National Laboratory who helps lead a consortium of the nation’s top cancer researchers through the Stand Up To Cancer initiative, will expand on the institute’s lead in making personalized cancer medicine a reality for all patients</p>
<div align="left">Internationally renowned cancer and genomic researcher <strong>Joe Gray, Ph.D.</strong>, of the Lawrence Berkeley National Laboratory will join Oregon Health &#38; Science University’s Knight Cancer Institute and the School of Medicine. Gray is known for, among other things, developing the FISH test that transformed how treatments are selected for breast cancer patients. He co-leads the Stand Up To Cancer initiative’s “Breast Cancer Dream Team,” serves as a key player in the Cancer Genome Atlas Project and is spearheading the use of computer models to predict how promising targeted therapies will work in attacking cancer cells.Gray will head OHSU’s newly created Center for Spatial Systems Biomedicine, which will use a combination of physics, biomedical engineering, chemistry and biology to study how cancer cells grow. He also will serve as the new chair of the Department of Biomedical Engineering and will contribute to OHSU’s strategic alliance with Portland State University to elevate research conducted by both institutions through shared resources and capabilities. He will be joined at OHSU by members of his current research team.Advancing research into personalized cancer medicine with experts such as Gray is part of the OHSU Knight Cancer Institute’s strategic plan to leverage the $100 million gift from Nike Chairman Phil Knight and his wife, Penny.</div>]]></description>
				<content:encoded><![CDATA[<p>Oregon Health Sciences Institute</p>
<p><span id="more-207"></span></p>
<p><img class="size-full wp-image-243 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="Gray-Joe" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/111028-Gray-Joe120_2.jpg" alt="Gray-Joe" width="120" height="135" />Gray, a renowned genomics expert at Lawrence Berkeley National Laboratory who helps lead a consortium of the nation’s top cancer researchers through the Stand Up To Cancer initiative, will expand on the institute’s lead in making personalized cancer medicine a reality for all patients</p>
<div align="left">Internationally renowned cancer and genomic researcher <strong>Joe Gray, Ph.D.</strong>, of the Lawrence Berkeley National Laboratory will join Oregon Health &amp; Science University’s Knight Cancer Institute and the School of Medicine. Gray is known for, among other things, developing the FISH test that transformed how treatments are selected for breast cancer patients. He co-leads the Stand Up To Cancer initiative’s “Breast Cancer Dream Team,” serves as a key player in the Cancer Genome Atlas Project and is spearheading the use of computer models to predict how promising targeted therapies will work in attacking cancer cells.Gray will head OHSU’s newly created Center for Spatial Systems Biomedicine, which will use a combination of physics, biomedical engineering, chemistry and biology to study how cancer cells grow. He also will serve as the new chair of the Department of Biomedical Engineering and will contribute to OHSU’s strategic alliance with Portland State University to elevate research conducted by both institutions through shared resources and capabilities. He will be joined at OHSU by members of his current research team.Advancing research into personalized cancer medicine with experts such as Gray is part of the OHSU Knight Cancer Institute’s strategic plan to leverage the $100 million gift from Nike Chairman Phil Knight and his wife, Penny.</div>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/joe-gray/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>SIMON CHERRY</title>
		<link>http://www.biomedicalimaging.org/2013/simon-cherry/</link>
		<comments>http://www.biomedicalimaging.org/2013/simon-cherry/#comments</comments>
		<pubDate>Thu, 07 Jun 2012 22:51:39 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[homespeakers]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=195</guid>
		<description><![CDATA[<p>University of California, Davis</p>
<p><span id="more-195"></span></p>
<p>&#160;</p>
<table border="0" cellspacing="2" cellpadding="0">
<tbody>
<tr>
<td><strong><img class="size-thumbnail wp-image-240 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="Cherry-Simon" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/Cherry-Simon_001-150x150.jpg" alt="Cherry-Simon" width="150" height="150" />Personal Education<br />
</strong>Ph.D. in Medical Physics, University of London, United Kingdom 1989</td>
</tr>
<tr>
<td><strong>Affiliation</strong><a href="http://imaging.bme.ucdavis.edu/" target="_blank">Center for Molecular and Genomic Imaging</a><br />
Biomedical Engineering Graduate Group<strong>Research Interest<br />
</strong><em>Molecular Imaging, Technology Development:</em><br />
Simon Cherry’s research involves the rapidly growing field of molecular imaging. The basic concept behind molecular imaging is the use of non-invasive imaging technologies to visualize and characterize specific molecular events and targets in vivo. Areas of active research include the development of new and improved imaging technologies, the design of novel contrast agents and imaging probes and their application in molecular diagnostics and therapeutics. Professor Cherry and the members of his laboratory team are particularly interested in developing new technologies and techniques for in vivo molecular imaging. They focus on a nuclear imaging technique, positron emission tomography (PET), and its application in studying animal models of human disease. They are also exploring the integration of PET imaging technology with the highresolution anatomical imaging provided by magnetic resonance imaging (MRI) or x-ray computed tomography (CT). The use of molecular imaging technologies for phenotyping and for the development and validation of new drugs and therapeutic approaches are among the applications they are pursuing. The research group has many active projects in the laboratory, ranging from the development of new detector technologies for imaging to the building of complete imaging systems for specific biological or medical applications. The research associated with these projects involves novel detector development; system simulation and design; the investigation of data acquisition and correction strategies; the study of three-dimensional image reconstruction algorithms; new software tools for the visualization, analysis, and quantification of imaging data; and the application of molecular imaging technologies to important problems in medicine and biology.
<p><strong>Research Facility<br />
</strong></p>
<p><a href="http://www.bme.ucdavis.edu/cherrylab/" target="_blank">Dr. Cherry’s Lab</a></p>
<p><strong>Research Papers<br />
</strong></p>
<p>Zavattini G, Vecchi S, Mitchell G, Weisser U, Leahy RM, Pichler BJ, Smith DJ, <strong>Cherry SR</strong>.  A hyperspectral fluorescence system for 3D in vivo optical imaging.  <em>Phys Med Biol </em>2006; 51: 2029-2043<em>.</em></p>
<p>Yang YF, Dokhale PA, Silverman RW, Shah KS, McClish MA, Farrell R, Entine G, <strong>Cherry SR</strong>.  Depth of interaction resolution measurements for a high resolution PET detector using position sensitive avalanche photodiodes.  <em>Phys Med Biol</em> 2006; 51: 2131-2142.<br />
<strong><br />
Cherry SR</strong>. The 2006 Henry N. Wagner Lecture: Of Mice and Men (and Positrons) – Advances in PET imaging technology.  <em>J Nucl Med</em> 2006; 47: 1735-1745.</p>
<p>Catana C, Wu Y, Judenhofer MS, Qi J, Pichler BJ, <strong>Cherry SR</strong>.</p></td></tr></tbody></table>]]></description>
				<content:encoded><![CDATA[<p>University of California, Davis</p>
<p><span id="more-195"></span></p>
<p>&nbsp;</p>
<table border="0" cellspacing="2" cellpadding="0">
<tbody>
<tr>
<td><strong><img class="size-thumbnail wp-image-240 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="Cherry-Simon" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/Cherry-Simon_001-150x150.jpg" alt="Cherry-Simon" width="150" height="150" />Personal Education<br />
</strong>Ph.D. in Medical Physics, University of London, United Kingdom 1989</td>
</tr>
<tr>
<td><strong>Affiliation</strong><a href="http://imaging.bme.ucdavis.edu/" target="_blank">Center for Molecular and Genomic Imaging</a><br />
Biomedical Engineering Graduate Group<strong>Research Interest<br />
</strong><em>Molecular Imaging, Technology Development:</em><br />
Simon Cherry’s research involves the rapidly growing field of molecular imaging. The basic concept behind molecular imaging is the use of non-invasive imaging technologies to visualize and characterize specific molecular events and targets in vivo. Areas of active research include the development of new and improved imaging technologies, the design of novel contrast agents and imaging probes and their application in molecular diagnostics and therapeutics. Professor Cherry and the members of his laboratory team are particularly interested in developing new technologies and techniques for in vivo molecular imaging. They focus on a nuclear imaging technique, positron emission tomography (PET), and its application in studying animal models of human disease. They are also exploring the integration of PET imaging technology with the highresolution anatomical imaging provided by magnetic resonance imaging (MRI) or x-ray computed tomography (CT). The use of molecular imaging technologies for phenotyping and for the development and validation of new drugs and therapeutic approaches are among the applications they are pursuing. The research group has many active projects in the laboratory, ranging from the development of new detector technologies for imaging to the building of complete imaging systems for specific biological or medical applications. The research associated with these projects involves novel detector development; system simulation and design; the investigation of data acquisition and correction strategies; the study of three-dimensional image reconstruction algorithms; new software tools for the visualization, analysis, and quantification of imaging data; and the application of molecular imaging technologies to important problems in medicine and biology.</p>
<p><strong>Research Facility<br />
</strong></p>
<p><a href="http://www.bme.ucdavis.edu/cherrylab/" target="_blank">Dr. Cherry’s Lab</a></p>
<p><strong>Research Papers<br />
</strong></p>
<p>Zavattini G, Vecchi S, Mitchell G, Weisser U, Leahy RM, Pichler BJ, Smith DJ, <strong>Cherry SR</strong>.  A hyperspectral fluorescence system for 3D in vivo optical imaging.  <em>Phys Med Biol </em>2006; 51: 2029-2043<em>.</em></p>
<p>Yang YF, Dokhale PA, Silverman RW, Shah KS, McClish MA, Farrell R, Entine G, <strong>Cherry SR</strong>.  Depth of interaction resolution measurements for a high resolution PET detector using position sensitive avalanche photodiodes.  <em>Phys Med Biol</em> 2006; 51: 2131-2142.<br />
<strong><br />
Cherry SR</strong>. The 2006 Henry N. Wagner Lecture: Of Mice and Men (and Positrons) – Advances in PET imaging technology.  <em>J Nucl Med</em> 2006; 47: 1735-1745.</p>
<p>Catana C, Wu Y, Judenhofer MS, Qi J, Pichler BJ, <strong>Cherry SR</strong>.  Simultaneous acquisition of multislice PET and MR images: initial results with a MR-compatible PET scanner.  <em>J Nucl Med</em> 2006; 47: 1968-1976.</p>
<p>Tarantal AF, Lee CCI, Jimenez DF, <strong>Cherry SR</strong>.  Fetal gene transfer using lentiviral vectors: In vivo detection of gene expression by microPET and optical imaging in fetal and infant monkeys.  <em>Hum Gene Ther</em> 2006; 17: 1254-1261.</p>
<p>Stickel JR, Qi J, <strong>Cherry SR</strong>.  Fabrication and characterization of a 0.5-mm lutetium oxyorthosilicate detector array for high-resolution PET applications<em>.  J Nucl Med</em> 2007; 48: 115-121.</p>
<p>Liang H, Yang Y, Yang K, Wu Y, Boone JM, and <strong>Cherry SR</strong>. A microPET/CT  system for in vivo small animal imaging. <em>Phys Med Biol</em>2007; 52:  3881-3894.</p>
<p>Du HN, Yan YF, <strong>Cherry SR</strong>. Measurements of wavelength shifting (WLS) fibre readout for a highly multiplexed, depth-encoding PET detector. <em>Phys Med Biol</em> 2007; 52:  2499-2514.</p>
<p><strong>Review Articles</strong><strong><br />
</strong></p>
<p><strong>Cherry SR</strong>. In vivo genomic and molecular imaging: new challenges for imaging physics.  <em>Phys Med Biol</em>2004; 49: R13-48.<br />
<strong>Cherry SR</strong>.  Multimodality in vivo imaging systems: Twice the power or double the trouble?  <em>Ann Rev Biomed Eng</em> 2006; 8: 35-62.</p>
<p><strong>Textbook</strong></p>
<p><strong>Cherry SR</strong>, Sorenson J, Phelps ME.  <em>Physics in Nuclear Medicine</em>.  3rd Edition, W.B. Saunders, New York,  2003.</p>
<p><strong>Major Research Interest<br />
</strong></p>
<p>Molecular imaging technology, particularly positron emission tomography, multi-modality imaging systems, gamma and x-ray detector technology,3-D image reconstruction and use of imaging techniques in phenotyping and drug development.</td>
</tr>
</tbody>
</table>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/simon-cherry/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>STEPHEN WONG – Methodist Hospital Research Institute</title>
		<link>http://www.biomedicalimaging.org/2013/stephen-wong-methodist-hospital-research-institute/</link>
		<comments>http://www.biomedicalimaging.org/2013/stephen-wong-methodist-hospital-research-institute/#comments</comments>
		<pubDate>Wed, 06 Jun 2012 21:55:44 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[speakers]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=178</guid>
		<description><![CDATA[<p><img class="size-thumbnail wp-image-288 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="Dr. Stephen Wong " alt="Dr. Stephen Wong" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/stephen-wong-thumb-150x150.jpg" width="150" height="150" />Dr. Wong is the Founding Chair for Department of Systems Medicine and Bioengineering, The Methodist Hospital Research Institute, where he holds the John S. Dunn, Sr. Distinguished Endowed Chair in Biomedical Engineering. He is also a Professor of Radiology, Pathology, Laboratory Medicine, Neurology, and Neurosciences at Cornell University; the Director of Translational Research at Methodist Cancer Center; Vice Chair of Radiology, Chief of Medical Physics, and Chief Research Information Officer at The Methodist Hospital at Texas Medical Center.<br />
Dr. Wong has led teams that developed production automation for the first VLSI 1MB DRAM in 80s&#8217; and the largest online brokerage trading system in 90s&#8217;, and contributed to the development of the first hospital-wide picture archiving and communication system (PACS) in US academic medical centers.</p>]]></description>
				<content:encoded><![CDATA[<p><img class="size-thumbnail wp-image-288 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="Dr. Stephen Wong " alt="Dr. Stephen Wong" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/stephen-wong-thumb-150x150.jpg" width="150" height="150" />Dr. Wong is the Founding Chair for Department of Systems Medicine and Bioengineering, The Methodist Hospital Research Institute, where he holds the John S. Dunn, Sr. Distinguished Endowed Chair in Biomedical Engineering. He is also a Professor of Radiology, Pathology, Laboratory Medicine, Neurology, and Neurosciences at Cornell University; the Director of Translational Research at Methodist Cancer Center; Vice Chair of Radiology, Chief of Medical Physics, and Chief Research Information Officer at The Methodist Hospital at Texas Medical Center.<br />
Dr. Wong has led teams that developed production automation for the first VLSI 1MB DRAM in 80s&#8217; and the largest online brokerage trading system in 90s&#8217;, and contributed to the development of the first hospital-wide picture archiving and communication system (PACS) in US academic medical centers.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/stephen-wong-methodist-hospital-research-institute/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>JOHN SEDAT – University of California, San Francisco</title>
		<link>http://www.biomedicalimaging.org/2013/john-sedat-university-of-california-san-francisco/</link>
		<comments>http://www.biomedicalimaging.org/2013/john-sedat-university-of-california-san-francisco/#comments</comments>
		<pubDate>Wed, 06 Jun 2012 21:55:23 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[speakers]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=176</guid>
		<description><![CDATA[<p><strong><img class="size-thumbnail wp-image-290 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="John Sedat " src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/John-Sedat-thumb-150x150.jpg" alt="John Sedat" width="150" height="150" />John Sedat</strong> is Professor Emeritus in Biochemistry and Biophysics at the University of California, San Francisco. He received his Ph.D. in Biology from Caltech in Pasadena, CA in 1970 followed by postdoctoral study under Fred Sanger at the MRC in Cambridge, England. Subsequently, he spent approximately a year at the Hebrew University at Hadassah in Jerusalem, Israel where the Drosophila and chromosome study started.  Several years at Yale followed, and he has been at UCSF since 1977.</p>]]></description>
				<content:encoded><![CDATA[<p><strong><img class="size-thumbnail wp-image-290 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="John Sedat " src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/John-Sedat-thumb-150x150.jpg" alt="John Sedat" width="150" height="150" />John Sedat</strong> is Professor Emeritus in Biochemistry and Biophysics at the University of California, San Francisco. He received his Ph.D. in Biology from Caltech in Pasadena, CA in 1970 followed by postdoctoral study under Fred Sanger at the MRC in Cambridge, England. Subsequently, he spent approximately a year at the Hebrew University at Hadassah in Jerusalem, Israel where the Drosophila and chromosome study started.  Several years at Yale followed, and he has been at UCSF since 1977.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/john-sedat-university-of-california-san-francisco/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>DAVID DONOHO – Stanford University</title>
		<link>http://www.biomedicalimaging.org/2013/devid-donoho-stanford-university/</link>
		<comments>http://www.biomedicalimaging.org/2013/devid-donoho-stanford-university/#comments</comments>
		<pubDate>Wed, 06 Jun 2012 21:53:12 +0000</pubDate>
		<dc:creator>ravichoudhary09</dc:creator>
				<category><![CDATA[speakers]]></category>

		<guid isPermaLink="false">http://www.biomedicalimaging.org/2013/?p=171</guid>
		<description><![CDATA[<p><img class="size-thumbnail wp-image-292 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="David Dohono" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/david-dohono-150x150.jpg" alt="David Dohono" width="150" height="150" /></p>
<p><strong>Donoho</strong> is a mathematician who has made fundamental contributions to theoretical and computational statistics, as well as to signal processing and harmonic analysis. His algorithms have contributed significantly to our understanding of the maximum entropy principle, of the structure of robust procedures, and of sparse data description.</p>
<p><strong>Research Interests</strong><br />
My theoretical research interests have focused on the mathematics of statistical inference and on theoretical questions arising in applying harmonic analysis to various applied problems. My applied research interests have ranged from data visualization to various problems in scientific signal processing, image processing, and inverse problems.</p>]]></description>
				<content:encoded><![CDATA[<p><img class="size-thumbnail wp-image-292 alignleft" style="margin-top: 0px; margin-bottom: 5px; margin-left: 0px; margin-right: 15px;" title="David Dohono" src="http://www.biomedicalimaging.org/2013/wp-content/uploads/2012/06/david-dohono-150x150.jpg" alt="David Dohono" width="150" height="150" /></p>
<p><strong>Donoho</strong> is a mathematician who has made fundamental contributions to theoretical and computational statistics, as well as to signal processing and harmonic analysis. His algorithms have contributed significantly to our understanding of the maximum entropy principle, of the structure of robust procedures, and of sparse data description.</p>
<p><strong>Research Interests</strong><br />
My theoretical research interests have focused on the mathematics of statistical inference and on theoretical questions arising in applying harmonic analysis to various applied problems. My applied research interests have ranged from data visualization to various problems in scientific signal processing, image processing, and inverse problems.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.biomedicalimaging.org/2013/devid-donoho-stanford-university/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
